Deliver a professional HPV-related cancer prevention service through Scripter's structured consultation pathway. Supply: 9-valent human papillomavirus vaccine (Gardasil 9).
The 9-valent HPV vaccine protects against the virus types responsible for most cervical, anal, penile and throat cancers and genital warts. The private service covers people who missed the school programme or are outside its age range, with the number of doses set by age at first dose.
Human papillomavirus is a common sexually transmitted infection; most people clear it, but persistent infection with high-risk types drives several cancers. Vaccination before or early in sexual activity gives the strongest protection, but later vaccination still has value.
Patients book online, complete the pre-consultation questionnaire, and the guided pathway walks the practitioner through the HPV-related cancer prevention consultation with the screening and counselling steps built in. The supply decision, the record and any GP notification are produced in the same flow, documented against the exact protocol version in force.
Who can deliver this service, and who it can be delivered to. The governing PGD document defines the definitive inclusion, exclusion and supply criteria; the Scripter consultation pathway enforces them, and every consultation is documented against the protocol version it ran under.
Related protocols in the same category, all delivered through the same platform.
Chickenpox prevention
View PGDShingles prevention
View PGDMeasles, mumps and rubella protection
View PGDRSV protection in older adults
View PGDMeningococcal B protection
View PGDOccupational hepatitis B protection
View PGDSee the consultation pathway, the sign-off tracking and the record it produces in a free 30-minute demo.